StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
255
This month
2
This year
9
Publishing Date
2023 - 03 - 18
3
2023 - 03 - 17
3
2023 - 03 - 11
2
2023 - 03 - 07
5
2023 - 03 - 04
3
2023 - 02 - 26
2
2023 - 02 - 18
3
2023 - 02 - 13
2
2023 - 02 - 07
2
2023 - 02 - 01
2
2022 - 12 - 10
2
2022 - 11 - 03
2
2021 - 12 - 24
3
2021 - 12 - 15
3
2021 - 12 - 13
2
2021 - 12 - 04
3
2021 - 11 - 15
3
2021 - 11 - 04
3
2021 - 10 - 30
6
2021 - 10 - 22
2
2021 - 10 - 20
6
2021 - 10 - 08
4
2021 - 09 - 27
6
2021 - 09 - 21
3
2021 - 09 - 14
2
2021 - 09 - 13
11
2021 - 09 - 03
5
2021 - 08 - 20
13
2021 - 08 - 03
3
2021 - 07 - 26
4
2021 - 07 - 02
7
2021 - 06 - 04
2
2021 - 05 - 28
2
2021 - 05 - 25
7
2021 - 05 - 21
2
2021 - 05 - 17
5
2021 - 04 - 27
3
2021 - 04 - 23
4
2021 - 04 - 22
1
2021 - 04 - 19
3
2021 - 04 - 16
1
2021 - 04 - 15
1
2021 - 04 - 13
1
2021 - 04 - 12
2
2021 - 04 - 02
3
2021 - 04 - 01
4
2021 - 03 - 30
1
2021 - 03 - 29
5
2021 - 03 - 26
3
2021 - 03 - 25
2
2021 - 03 - 24
1
2021 - 03 - 08
1
2021 - 02 - 24
1
2021 - 02 - 22
1
2021 - 02 - 19
1
2021 - 01 - 08
1
2021 - 01 - 06
1
2021 - 01 - 04
1
2020 - 12 - 06
1
2020 - 12 - 04
1
Sector
Commercial services
4
Communications
2
Consumer durables
1
Consumer non-durables
1
Educational services
1
Electronic technology
2
Finance
5
Health technology
255
Information
6
Manufacturing
7
N/a
8
Process industries
3
Producer manufacturing
7
Professional, scientific, and technical services
1
Technology services
3
Transportation and warehousing
1
Tags
5g
1
Acquisition
3
Advanced
1
Agreement
1
Aml
2
Analytics
1
Award
2
Biopharma
4
Biotech-beach
7
Blockchain
2
Business
2
Cancer
10
Car-t
2
Cel
2
Chmp
6
Collaboration
2
Companies
2
Conference
14
Contract
2
Control
2
Deadline
26
Drug
3
Employee
4
Events
2
Financial
8
Financial results
4
Genome editing
2
Genomic
2
Global
3
Immunotherapy
10
Iot
2
Market
3
Meeting
5
Molecular
6
N/a
238
Nasdaq
4
Offering
4
People
3
Phase 1
6
Phase 2
2
Phase 3
2
Positive
5
Preclinical
3
Presentation
4
Program
3
Report
3
Research
29
Results
13
Software
2
Solid tumors
2
Stem cell
2
System
4
T-cell
11
Therapeutics
40
Therapy
15
Train
3
Treatment
2
Trial
13
Trusted
3
Year
3
Entities
Affimed n.v.
1
Akero therapeutics, inc.
2
Alico, inc.
3
Alphabet inc.
1
Amgen inc.
1
Anixa biosciences, inc.
1
Argo blockchain plc
5
Avaya holdings corp.
1
Bellicum pharmaceuticals, inc.
1
Biolinerx ltd.
5
Bioventus inc - class a
1
Bristol-myers squibb company
1
Caribou biosciences inc
1
Centurylink, inc. d/b/a lumen technologies, inc.
1
Charles river laboratories international, inc.
3
Cognyte software ltd
1
Consensus cloud solutions, inc.
2
Daktronics, inc.
1
Draftkings inc.
1
Enovix corporation
2
Epizyme, inc.
1
Evotec se
1
Fate therapeutics, inc.
255
Gaotu techedu inc - adr
1
Gilead sciences, inc.
2
Glaxosmithkline plc
1
Gritstone oncology, inc.
1
Gt biopharma inc
3
Hesai group
2
Honda motor company, ltd.
1
Innate pharma sa
1
International business machines corporation
1
Invivyd inc
3
Iris energy ltd
1
Johnson & johnson
4
Kornit digital ltd.
7
Legend biotech corporation
2
Mei pharma, inc.
1
Morgan stanley
2
Mustang bio, inc.
1
Newage, inc.
1
Nkarta, inc.
1
Phathom pharmaceuticals, inc.
1
Pldt inc.
1
Poseida therapeutics, inc.
1
Precigen, inc.
1
Provident bancorp, inc.
2
Ryvyl inc
1
Sanofi
2
Silvergate capital corporation
1
Singularity future technology ltd
1
Sorrento therapeutics, inc.
1
Sotera health company
1
Takeda pharmaceutical company limited
1
Twist bioscience corporation
1
Vistagen therapeutics, inc.
1
Xilio therapeutics inc
1
Y-mabs therapeutics, inc.
3
Symbols
A
429
ABBV
1024
ABT
1787
ALPMF
332
ALPMY
332
AMGN
742
AZN
665
AZNCF
448
BAX
483
BDX
796
BGNE
323
BHC
389
BIIB
381
BIO
449
BMY
662
BNTX
366
BSX
575
BWAY
330
DHR
785
FNCTF
489
GILD
500
GLAXF
658
GMAB
297
GOOG
301
GOOGL
302
GSK
884
HEPA
404
HOLX
328
ILMN
451
INCY
444
JNJ
4583
LLY
1709
MDT
1285
MOR
314
MPSYF
270
MRK
337
MRNA
349
MS
620
NKTR
366
NVO
632
NVS
1241
NVSEF
1031
OCX
482
PFE
692
PHG
962
PKI
274
PRVB
348
QGEN
369
REGN
419
RYLPF
440
SNY
4539
SNYNF
3597
STRO
270
SYK
536
TAK
421
TEVJF
631
TMO
1623
TXMD
278
VTRS
364
VXRT
314
Exchanges
Nasdaq
255
Nyse
18
Crawled Date
2023 - 03 - 19
2
2023 - 03 - 17
3
2023 - 03 - 11
2
2023 - 03 - 07
5
2023 - 03 - 04
2
2023 - 02 - 27
2
2023 - 02 - 18
3
2023 - 02 - 13
2
2023 - 02 - 07
2
2023 - 02 - 02
3
2022 - 12 - 10
2
2022 - 11 - 03
2
2021 - 12 - 24
3
2021 - 12 - 15
3
2021 - 12 - 13
2
2021 - 12 - 04
3
2021 - 11 - 15
3
2021 - 11 - 04
3
2021 - 10 - 30
6
2021 - 10 - 23
2
2021 - 10 - 21
6
2021 - 10 - 08
4
2021 - 09 - 28
6
2021 - 09 - 21
3
2021 - 09 - 14
2
2021 - 09 - 13
11
2021 - 09 - 03
5
2021 - 08 - 20
13
2021 - 08 - 03
3
2021 - 07 - 26
4
2021 - 07 - 02
7
2021 - 06 - 08
1
2021 - 06 - 04
2
2021 - 05 - 28
2
2021 - 05 - 25
7
2021 - 05 - 21
2
2021 - 05 - 17
5
2021 - 05 - 05
1
2021 - 04 - 28
1
2021 - 04 - 27
3
2021 - 04 - 23
4
2021 - 04 - 22
1
2021 - 04 - 19
3
2021 - 04 - 17
1
2021 - 04 - 15
1
2021 - 04 - 13
3
2021 - 04 - 02
3
2021 - 04 - 01
4
2021 - 03 - 30
6
2021 - 03 - 26
3
2021 - 03 - 25
3
2021 - 03 - 08
1
2021 - 02 - 24
1
2021 - 02 - 22
1
2021 - 02 - 19
1
2021 - 01 - 08
1
2021 - 01 - 06
1
2021 - 01 - 04
1
2020 - 12 - 06
1
2020 - 12 - 04
1
Crawled Time
00:00
23
00:20
7
01:00
11
02:00
5
04:20
3
05:00
1
06:00
1
08:20
6
08:23
6
09:00
1
10:00
1
11:00
8
12:00
5
12:01
1
12:02
1
12:15
3
12:20
2
12:30
1
13:00
8
13:02
1
13:20
2
14:00
5
14:15
1
14:20
3
15:00
5
15:06
1
16:00
6
16:20
3
17:00
35
18:00
14
19:00
22
20:00
14
20:20
11
21:00
9
21:02
3
21:03
1
22:00
13
23:00
12
Source
www.biospace.com
15
www.fatetherapeutics.com
150
www.globenewswire.com
44
www.prnewswire.com
46
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
Fate
save search
Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference
Published:
2024-04-03
(Crawled : 19:00)
- biospace.com/
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-29.56%
|
O:
-0.29%
H:
7.52%
C:
3.39%
conference
therapeutics
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-04-02
(Crawled : 20:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-29.56%
|
O:
-0.29%
H:
7.52%
C:
3.39%
award
nasdaq
therapeutics
employee
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
Published:
2024-03-19
(Crawled : 12:30)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-31.96%
|
O:
-2.98%
H:
6.59%
C:
2.49%
million
offering
therapeutics
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-03-05
(Crawled : 21:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-30.88%
|
O:
3.32%
H:
12.71%
C:
11.45%
award
nasdaq
therapeutics
employee
Fate Therapeutics to Present at Upcoming March Investor Conferences
Published:
2024-03-01
(Crawled : 13:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-32.44%
|
O:
0.99%
H:
8.94%
C:
8.1%
therapeutics
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Published:
2024-02-26
(Crawled : 21:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-31.08%
|
O:
8.78%
H:
14.15%
C:
-1.32%
business
year
therapeutics
financial
results
Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-15
(Crawled : 13:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-26.19%
|
O:
2.16%
H:
8.6%
C:
6.79%
conference
year
therapeutics
financial
results
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-02-02
(Crawled : 21:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
nasdaq
awards
therapeutics
employee
Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
27.06%
|
O:
0.8%
H:
13.16%
C:
8.42%
ft825
tumors
trial
therapeutics
advanced
Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-12-13
(Crawled : 22:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
78.73%
|
O:
5.22%
H:
7.09%
C:
5.67%
nasdaq
grants
therapeutics
employee
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2023 Financial Results
Published:
2023-10-25
(Crawled : 12:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
146.91%
|
O:
0.52%
H:
1.03%
C:
-7.69%
conference
therapeutics
financial
results
SHORELINE BIOSCIENCES WINS A COMPREHENSIVE SUMMARY JUDGEMENT VICTORY ON ALL CLAIMS BROUGHT BY FATE THERAPEUTICS AND WHITEHEAD INSTITUTE ON IPSC GENERATION AND USE
Published:
2023-09-07
(Crawled : 12:00)
- prnewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
84.23%
|
O:
-1.92%
H:
0.39%
C:
-3.14%
institute
therapeutics
Fate Therapeutics to Present at Upcoming September Investor Conferences
Published:
2023-08-31
(Crawled : 12:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
81.44%
|
O:
0.0%
H:
0.76%
C:
-4.92%
therapeutics
Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2023 Financial Results
Published:
2023-07-28
(Crawled : 12:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
16.83%
|
O:
2.44%
H:
2.62%
C:
0.24%
conference
therapeutics
financial
results
Fate Therapeutics to Present at Upcoming June Investor Conferences
Published:
2023-05-31
(Crawled : 12:01)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-3.43%
|
O:
0.0%
H:
6.25%
C:
1.81%
therapeutics
Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates
Published:
2023-05-03
(Crawled : 20:00)
- globenewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-24.21%
|
O:
-5.06%
H:
10.0%
C:
2.83%
business
therapeutics
financial
results
Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2023 Financial Results
Published:
2023-04-24
(Crawled : 13:00)
- biospace.com/
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-22.99%
|
O:
2.25%
H:
0.63%
C:
-0.31%
conference
therapeutics
financial
results
FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders
Published:
2023-03-21
(Crawled : 10:00)
- prnewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
-13.85%
|
O:
0.9%
H:
0.0%
C:
-3.39%
deadline
HSAI INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Hesai Group Investors to Inquire About Securities Class Action Investigation - HSAI
Published:
2023-03-18
(Crawled : 00:20)
- prnewswire.com
CRL
|
$226.78
-0.34%
0.0%
410K
|
Commercial Services
|
Email alert
Add to watchlist
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
HSAI
|
$3.97
-7.24%
-7.81%
330K
|
n/a
|
Email alert
Add to watchlist
trusted
group
GOOG, GOOGL EQUITY ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Alphabet Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GOOG, GOOGL
Published:
2023-03-18
(Crawled : 00:20)
- prnewswire.com
FATE
|
$4.795
-4.86%
-5.11%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
GOOG
|
News
S
|
$155.7
-1.12%
-1.13%
20M
|
Technology Services
|
Email alert
Add to watchlist
GOOGL
|
News
S
|
$154.08
-1.24%
-1.25%
32M
|
Technology Services
|
Email alert
Add to watchlist
HSAI
|
$3.97
-7.24%
-7.81%
330K
|
n/a
|
Email alert
Add to watchlist
deadline
trial
← Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.